JUBILANT LIFE SCIENCES LIMITED - Jubilant Biosys Enters into Exclusive out - Licensing Agreement with Checkpoint Therapeutics for Novel BET Inhibitors

27 May 2016

Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated May 27, 2016 titled "Jubilant Biosys Enters into Exclusive out - Licensing Agreement with Checkpoint Therapeutics for Novel BET Inhibitors".

Source: BSE India

View all announcements for JUBILANT LIFE SCIENCES LIMITED

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist